Polymorphism of some JAK-STAT pathway genes and its regulators in patients with systemic lupus erythematosus and lupus nephritis in Repubic of Belarus
https://doi.org/10.29235/1561-8323-2023-67-3-222-230
Abstract
Genes of interest – STAT4, PTPN2 and PTPN22 – are components of the JAK-STAT signaling pathway, one of the important regulators of the immune system. The JAK-STAT pathway plays a key role in the development of both systemic lupus erythematosus (SLE) and its manifestation, lupus nephritis (LN) by mediating interferon levels and promoting IFN-induced gene expression. We investigated the allele and genotypes frequencies at the polymorphic loci of the STAT4 (rs7574865, rs3821236), PTPN2 (rs2542151, rs7234029) and PTPN22 (rs2476601) genes in groups of children (n = 37) and adults (n = 63) with SLE and LN. The control group included children (n = 420) and adults (n = 345) without autoimmune diseases. The analysis of the combined group of pediatric and adult patients revealed that the rs7574865 polymorphic locus of the STAT4 gene is associated with the risk of developing SLE (Т: OR 1,99 [1,42–2,79], р = 0,0001; TT: OR 3,36 [1,64–6,87], р = 0,0018) and LN (Т: OR 1,91 [1,32–2,78], р = 0,0008; TT: OR 4,25 [2,02–8,95], р = 0,0004). These associations also persisted when analyzing the pediatric and adult groups of patients with SLE and LN separately. Moreover, the rs7574865 polymorphic locus of the STAT4 gene appears to be a common genetic risk factor for autoimmune diseases development. The association of the polymorphic locus rs2542151 of the PTPN2 gene with the SLE (G: OR 1,66 [1,12–2,47], p = 0,014; GT: OR 1,74 [1,10–2,77], р = 0,021) and LN (G: OR 1,87 [1,21–2,88], р = 0,006; GT: OR 1,90 [1,13–3,18], р = 0,017) susceptibility was also found in a combined group of patients. The polymorphic loci rs7234029 in the PTPN2 gene and rs2476601 in the PTPN22 gene were not associated with SLE or LN regardless of the age of the patients.
About the Authors
N. V. NikitchenkoBelarus
Nikitchenko Natallia V. – Researcher
27, Akademicheskaya Str., 220072, Minsk, Republic of Belarus
H. A. Yatskiu
Belarus
Yatskiu Hanna A. – Senior Researcher
27, Akademicheskaya Str., 220072, Minsk, Republic of Belarus
E. S. Siniauskaya
Belarus
Siniauskaya Elizabeth S. – Junior Researcher
27, Akademicheskaya Str., 220072, Minsk, Republic of Belarus
H. G. Bialkevich
Belarus
Bialkevich Hanna G. – Ph. D. (Medicine)\
83, Dzerzhinski Ave., 220116, Minsk, Republic of Belarus
I. A. Kazyra
Belarus
Kazyra Ina A. – D. Sc. (Medicine)
83, Dzerzhinski Ave., 220116, Minsk, Republic of Belarus
N. Yu. Dostanko
Russian Federation
Dostanko Natalia Yu. – Ph. D. (Medicine)
83, Dzerzhinski Ave., 220116, Minsk, Republic of Belarus
V. E. Yagur
Belarus
Yagur Victor E. – D. Sc. (Medicine), Professor
83, Dzerzhinski Ave., 220116, Minsk, Republic of Belarus
R. I. Goncharova
Belarus
Goncharova Roza I. – D. Sc. (Biology), Professor, Chief Researcher
27, Akademicheskaya Str., 220072, Minsk, Republic of Belarus
References
1. Kozyro I. A., Sukalo A. V. Systemic lupus erythematosus with kidney damage in children. Minsk, 2021. 214 p. (in Russian).
2. Yagur V. E., Chizh K. A., Soroka N. F., Dostanko N. Yu., Apanasovich V. G., Tarasevich T. V. Primary and general incidence of rheumatoid arthritis and systemic connective tissue diseases among adults in Minsk according to official statistics for 2001–2005. Zdravookhranenie [Healthcare], 2009, no. 2, pp. 39–42 (in Russian).
3. Mohan C., Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nature Reviews Nephrology, 2015, vol. 11, no. 6, pp. 329–341. https://doi.org/10.1038/nrneph.2015.33
4. Ikeda K., Hayakawa K., Fujishiro M., Kawasaki M., Hirai T., Tsushima H., Miyashita T., Suzuki S., Morimoto S., Tamura N., Takamori K., Ogawa H., Sekigawa I. JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation. BMC Immunology, 2017, vol. 18, no. 1, art. 41. https://doi.org/10.1186/s12865-017-0225-9
5. Yamamoto K., Okada Y. Shared genetic factors and their causality in autoimmune diseases. Annals of the Rheumatic Diseases, 2019, vol. 78, no. 11, pp. 1449–1451. https://doi.org/10.1136/annrheumdis-2019-215099
6. Yatskiv A. A., Kuzhir T. D., Sechko E. V., Chichko A. M., Myslivets M. G., Chizhevskaya I. D., Bil’skaya N. L., Sukalo A. V., Goncharova R. I. Polymorphism of immune and inflammatory response genes in children with articular syndrome. Molekulyarnaya i prikladnaya genetika [Molecular and Applied Genetics], 2019, vol. 27, pp. 5–16 (in Russian).
7. Sinyavskaya E. S., Kozyro I. A., Sukalo A. V., Goncharova R. I. Polymorphism of STAT4, PD-1, PD-L1 genes in children with systemic lupus erythematosus and lupus nephritis. Molekulyarnaya i prikladnaya genetika [Molecular and Applied Genetics], 2019, vol. 27, pp. 25–32 (in Russian).
8. Wang J.-M., Xu W.-D., Huang an-F. Association of STAT4 gene rs7574865, rs10168266 polymorphisms and systemic lupus erythematosus susceptibility: A meta-analysis. Immunological Investigations, 2021, vol. 50, no. 2–3, pp. 282–294. https://doi.org/10.1080/08820139.2020.1752712
9. Abelson A. K., Delgado-Vega A. M., Kozyrev S. V., Sánchez E., Velazquez-Cruz R., Eriksson N., Wojcik J. [et al.] STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Annals of the Rheumatic Diseases, 2009, vol. 68, no. 11, pp. 1746–1753. https://doi:10.1136/ard.2008.097642
10. Hagberg N., Lundtoft C., Rönnblom L. Immunogenetics in Systemic Lupus Erythematosus: Transitioning from Genetic Associations to Cellular Effects. Scandinavian Journal of Immunology, 2020, vol. 92, no. 4, art. e12894. https://doi.org/10.1111/sji.12894
11. Namjou B., Sestak A. L., Armstrong D. L., Zidovetzki R., Kelly J. A., Jacob N., Ciobanu V. [et al.]. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis & Rheumatology, 2009, vol. 60, no. 4, pp. 1085–1095. https://doi.org/10.1002/art.24387
12. Taylor K. E., Remmers E. F., Lee A. T., Ortmann W. A., Plenge R. M., Tian C., Chung S. A. [et al.]. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genetics, 2008, vol. 4, no. 5, art. e1000084. https://doi.org/10.1371/journal.pgen.1000084
13. Chistiakov D. A., Chistiakova E. I. T-cell protein tyrosine phosphatase: a role in inflammation and autoimmunity. International Journal of Diabetes Mellitus, 2010, vol. 2, no. 2, pp. 114–118. https://doi.org/10.1016/j.ijdm.2010.05.012
14. Ciccacci C., Perricone C., Ceccarelli F., Rufini S., Di Fusco D., Alessandri C., Spinelli F. R., Cipriano E., Novelli G., Valesini G., Borgiani P., Conti F. A Multilocus Genetic Study in a Cohort of Italian SLE Patients Confirms the Association with STAT4 Gene and Describes a New Association with HCP5 Gene. PLoS One, 2014, vol. 9, no. 11, art. e111991. https://doi.org/10.1371/journal.pone.0111991
15. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls / WTCCC (Welcome Trust Case Control Consortium). Nature, 2007, vol. 447, pp. 661–678.
16. Hu L.-Y., Cheng Z., Zhang B., Yin Q., Zhu X.-W., Zhao P.-P., Han M.-Y., Wang X.-B., Zheng H.-F. Associations between PTPN22 and TLR9 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis. Archives of Dermatological Research, 2017, vol. 309, no. 6, pp. 461–477. https://doi.org/10.1007/s00403-017-1745-0
17. Siniauskaya E., Yatskiu H., Dostanko N., Yagur V., Goncharova R. AB0016 Genetic variants of predisposition to rheumatoid arthritis in Belarusian population [EULAR Annual Congress, Copenhagen, June 1–4, 2022]. Annals of the Rheumatic Diseases, 2022, vol. 81, no. 1, art. 1143. https://doi.org/10.1136/annrheumdis-2022-eular.4519